Sunday July 05 2009 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
Panic Disorder News and Headlines
Panic Disorder News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's Panic Disorder
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Panic Disorder
.
Autonomic Activation During Sleep in Posttraumatic Stress Disorder and Panic: A Mattress Actigraphic Study
MDLinx:
similar ...
Psychiatric Treatment Received by Primary Care Patients With Panic Disorder With and Without Agoraphobia
MDLinx:
similar ...
Temporal Lobe Epilepsy Confused With Panic Disorder: Implications for Treatment
MDLinx:
similar ...
Potential Genetic Testing For Substance Abuse
Genomics & Genetics Weekly via NewsRx.com:
similar ...
Tikvah Therapeutics Signs Agreement to Develop and Commercialize Compounds to Treat Anxiety-Related Disorders
PR Newswire:
similar ...
MediciNova Announces Results From a Phase II/III Generalized Anxiety Disorder Trial With MN-305
PR Newswire:
similar ...
Lilly Submits Cymbalta Supplemental New Drug Application for Generalized Anxiety Disorder
Market Wire, Incorporated:
similar ...
Serotonin transporter gene promoter polymorphism affects paroxetine efficiency
Genomics & Genetics Weekly via NewsRx.com:
similar ...
Metabotropic glutamate II receptor agonist LY354740 ineffective in clinical trial
Pain & Central Nervous System Week via NewsRx.com:
similar ...
Lilly Plans to Submit Cymbalta(R) (duloxetine hydrochloride) New Drug Application for Generalized Anxiety Disorder
PR Newswire:
similar ...
EFFEXOR XR Approved for the Treatment of Panic Disorder
PR Newswire:
similar ...
MAO-A gene polymorphisms associated with panic attacks and GAD - Gene Polymorphisms
NewsRxGenomicsGenetics:
similar ...
Pivotal phase III trial begins for ocinaplon, an antianxiety drug candidate - Anxiety
NewsRxPainCNS:
similar ...
DOV Initiates Pivotal Phase III Trial for Ocinaplon, its Novel Anti-Anxiety Drug Candidate
PR Newswire:
similar ...
Repligen Initiates Clinical Trial of Secretin in Obsessive-Compulsive Disorder
PR Newswire:
similar ...
Forest Laboratories submits response for Lexapro for panic disorder.
CHEMICAL BUSINESS NEWSBASE - PRESS RELEASE:
similar ...
